Dr. Jeffrey L. Berenberg
Claim this profileStraub Clinic and Hospital
Expert in Lung Cancer
Expert in Parotid Gland Cancer
29 reported clinical trials
77 drugs studied
About Jeffrey L. Berenberg
Education:
- Obtained MD from the University of Miami School of Medicine in 1985.
- Completed Residency in Internal Medicine at Jackson Memorial Hospital (1985-1988).
- Undertook Fellowship in Gastroenterology at the University of Miami School of Medicine (1988-1991).
Experience:
- Practices as a gastroenterologist at Straub Clinic and Hospital.
Area of expertise
1Lung Cancer
Global LeaderStage III
Stage II
Stage IV
2Parotid Gland Cancer
Global LeaderStage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Jeffrey L. Berenberg is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Jeffrey L. Berenberg
Clinical Trial Related1 year of experience running clinical trials · Led 29 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Jeffrey L. Berenberg has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Carboplatin
- Gemcitabine Hydrochloride
- Radiation Therapy
Breakdown of trials Jeffrey L. Berenberg has run
Lung Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Jeffrey L. Berenberg specialize in?
Is Jeffrey L. Berenberg currently recruiting for clinical trials?
Are there any treatments that Jeffrey L. Berenberg has studied deeply?
What is the best way to schedule an appointment with Jeffrey L. Berenberg?
What is the office address of Jeffrey L. Berenberg?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.